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Abstract
Background
Interactions between diet, physical activity and genetic predisposition contribute to variable
body mass changes observed in response to weight loss interventions. Circulating micro-
RNAs (c-miRNAs) may act as ‘biomarkers’ that are associated with the rate of change in
weight loss, and/or play a role in regulating the biological variation, in response to energy
restriction.
Objective
To quantify targeted c-miRNAs with putative roles in energy metabolism and exercise adap-
tations following a 16 wk diet and exercise intervention in individuals with large (high respond-
ers; HiRes) versus small (low responders; LoRes) losses in body mass.
Methods
From 89 male and female overweight/obese participants who completed the intervention
(energy restriction from diet, 250 kcal/d, and exercise, 250 kcal/d), subgroups of HiRes
(>10% body mass loss, n = 22) and LoRes (<5% body mass loss, n = 18) were identified.
From resting plasma samples collected after an overnight fast pre and post intervention,
RNA was extracted, quantified and reverse transcribed. Thirteen c-miRNA selected a priori
were analysed using a customised 96-well miScript miRNA PCR Array.
Results
Loss of body mass (-11.0 ± 2.3 kg vs. -3.0 ± 1.3 kg; P<0.01) and fat mass (-11.1 ± 2.6 kg vs.
-3.9 ± 1.6 kg; P<0.01) was greater for HiRes than LoRes (P<0.001). Expression of c-miR-
935 was higher in LoRes compared to HiRes pre- (~47%; P = 0.025) and post- (~100%;
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P<0.01) intervention and was the only c-miRNA differentially expressed at baseline
between groups. The abundance of c-miR-221-3p and -223-3p increased pre- to post-inter-
vention in both groups (~57–69% and ~25–90%, P<0.05). There was a post-intervention
increase in c-miR-140 only in LoRes compared to HiRes (~23%, P = 0.016).
Conclusion
The differential expression and responses of selected c-miRNAs in overweight/obese indi-
viduals to an exercise and diet intervention suggests a putative role for these ‘biomarkers’ in
the prediction or detection of individual variability to weight loss interventions.
Introduction
Obesity is the excessive accumulation of fat mass resulting from a chronic imbalance between
energy intake and energy expenditure. Common behavioural strategies for weight management
and reducing fat mass include dietary energy restriction and increased energy expenditure
through physical activity [1]. However, there is a considerable inter-individual variability in
weight loss regardless of the weight loss strategy utilised [2–5]. While compliance to prescribed
diet and physical activity interventions undoubtedly contributes to the variance in fat loss
between individuals, differences in genotype may also be a determinant of the loss of fat during
any weight loss intervention [3–5]. Such variability in weight loss response may also, in part, be
attributed to epigenetic factors modulated by behavioural/environmental influences [3,6–8].
Small non-coding strands of RNA, microRNAs (miRNAs), are posttranscriptional regulators
of messenger RNA (mRNA) that promote mRNA degradation and thereby suppress or inhibit
translation [9]. While some miRNAs are highly expressed in various tissues throughout the body,
a subset of miRNAs are detectable in circulation (c-miRNAs) and can be transported to other tis-
sues and act in an endocrine manner on targeted cells [3–5,10]. To date, only one study has
reported a differential abundance of selected c-miRNAs associated with ‘high’ and ‘low’ respond-
ers following an 8-wk energy-restricted diet [4], while others have shown no significant differ-
ences before and after a 14-wk weight loss diet despite a 17% loss in body mass [11]. Of note,
these studies did not incorporate exercise prescription during the weight loss interventions. Exer-
cise confers multiple beneficial effects on musculoskeletal and cardiorespiratory health and is a
well-established modulator of gene expression that can also alter c-miRNA abundance [12,13].
The aim of the current study was to investigate whether the expression of specific c-miRNAs
previously shown to be modulated by energy restriction or exercise are ‘predictive’ of the mag-
nitude of weight loss between high’ and ‘low’ responders following a 16 wk diet and exercise
intervention. A second aim was to determine whether changes in these c-miRNAs as a result of
the weight loss intervention are associated with loss of body mass and changes in glucose toler-
ance. It was hypothesised there would be a differential abundance of c-miRNAs implicated in
the regulation of fat metabolism and exercise adaptation between high and low weight loss
responders both before and after the intervention.
Materials and Methods
Participants
One hundred and eleven males and females aged 35–59 years began a 16-wk weight loss inter-
vention incorporating diet and exercise modification, as previously described [14]. Prior to
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commencing the intervention, participants had a BMI of 27–40 kg/m2 and were sedentary but
otherwise apparently healthy. All participants gave written consent to participate in the inter-
vention. This was approved by RMIT Human Research Ethics Committee (76/11). The
trial was prospectively registered with the Australian New Zealand Clinical Trials Registry
(ACTRN12612000021875). Participants were recruited and participated in the trial between
March 2012 and October 2013. Of the initial participant cohort, 89 individuals successfully
completed the intervention and were subsequently ranked according to the magnitude of per-
centage body mass loss pre- to post intervention from highest to lowest (Fig 1), irrespective of
dietary group (as described below). From this ranking, participants were divided into quartiles
and the criteria for high and low responders was formulated based on the 1st vs 4th quartiles:
the upper quartile were individuals who had lost~10% (high responders) and the lower quar-
tile individuals who lost5% (low responders) of initial body mass. There were a total of 49
individuals that were categorized as losing5% or10% of initial body mass after the 16 wk
intervention.
Experimental Design
The experimental design has been described in detail elsewhere [14]. Briefly, participants com-
pleted a 16 wk intervention during which an energy deficit of 500 kcal was induced through an
energy restricted diet (~250 kcal) and daily exercise (~250 kcal). Participants were stratified
according to sex, age, and BMI and then randomly assigned to one of three dietary groups of
different macronutrient intake (high dairy protein, high carbohydrate (HDPHC) ~30% pro-
tein, 55% CHO, 15% fat; High dairy protein, moderate carbohydrate (HDPMC) ~30% protein,
40% CHO, 30% fat; Low dairy protein, high carbohydrate (control, CON) ~15% protein, 55%
CHO, 30% fat). For all groups, energy intake was restricted by 250 kcal/d based on estimated
energy balance requirements [15]. Body composition was measured via whole-body dual-
energy x-ray absorptiometry (DXA) scans (GE Lunar Prodigy Pro, GE Healthcare; software:
Encore 2009, version 12.20.033) before and after the 16 wk intervention. Dietary intake was
assessed through analysing 7 day food records in Foodworks1 Professional Edition Food Com-
position database (Version 7.0, Xyris Software Pty Ltd, QLD, Australia) collected in weeks 1, 4,
8, 12 and 16 and averaging intake across the study intervention period.
After an overnight fast participants reported to the laboratory for a DXA scan and fasted
blood samples were taken from an antecubital vein. Blood was collected in a non-additive tube
(9 mL) and immediately spun at 3000 g at 4°C for 10 min before analysis for insulin concentra-
tion and a EDTA tube (4 mL) was collected for baseline blood glucose analyses (YSI 2900, YSI
Life Sciences, Yellow Springs, OH, USA) as part of the oral glucose tolerance test (OGTT).
OGTT’s were conducted before and after the intervention period using a 75 g (300 mL) com-
mercially produced glucose solution (Point of Care Diagnostics, NSW, Australia) consumed
within 5 min. Sequential 4 mL blood samples were collected 30, 60, 90 and 120 min post-inges-
tion. The remaining sample was spun at 3000 g, 4°C, for 10 min and stored at -80°C for later
analysis. The homeostasis model assessment (HOMA) score was calculated from glucose and
insulin concentrations, as previously described [16].
Plasma RNA Extraction and Quantification
Plasma samples stored at -80°C were thawed on ice and subsequently centrifuged at 3000 g at
4°C for 10 min to pellet cell debris. Thereafter, 1.5 μL of plasma was loaded onto a NanoDrop
1000 spectrophotometer (Thermo Scientific, USA) to determine levels of free haemoglobin
[17]. Samples measuring above 0.20 at 414 nm (indicative of elevated free haemoglobin) were
excluded from further analysis (n = 6). 200 μL of the plasma was then transferred to a 1.5 mL
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Fig 1. Flowchart of participants throughout the 16 wk diet and exercise intervention and in the subsequent analysis of high (HiRes) and low
(LoRes) responders to the intervention. HDPHC, high dairy protein moderate fat; HDPMC, high dairy protein moderate fat; CON, control. Compliance was
to the diet and/or the exercise training.
doi:10.1371/journal.pone.0152545.g001
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tube and mixed with 1 mL Qiazol lysis reagent (Cat No. 217184; Qiagen, VIC, Australia) and
3.5 μL of miRNeasy Spike-In Control Caenorhabditis elegansmiR-39 (cel-miR-39; Qiagen,
VIC, Australia). 200 μL of chloroform was subsequently added to the samples and vortexed
for 15 s before being centrifuged at 12 000 g at 4°C for 15 min. The upper aqueous phase
(~600 μL) was then transferred to a 2 mL tube and mixed thoroughly with 100% ethanol.
Samples were transferred to RNeasy mini spin columns (Qiagen, VIC, Australia) in a 2 mL
collection tube and centrifuged at 8 000 g for 15 s at room temperature. After washing and
centrifuging with RWT and RPE buffers (Qiagen, VIC, Australia), columns were washed a
final time with 80% ethanol. Columns were then centrifuged with lids open to dry any residual
ethanol as per the manufactures directions. For RNA elution, columns were placed in a new 1.5
mL collection tube and 14 μL of RNase-free water was added directly to the spin column mem-
brane and centrifuged for 1 min at 16 000 g (maximum speed) at room temperature. Extracted
RNA was quantified using the NanoDrop 1000 spectrophotometer and measuring absorbance
at 260 nm and 280 nm and equilibrated with RNase-free water for subsequent cDNA synthesis.
Reverse Transcription (RT) and Pre-Amplification
50 ng RNA was reverse transcribed using a miScript II RT Kit (Cat. No. 218160, Qiagen, Mel-
bourne, Australia) in a BioRad thermal cycler (BioRad, Australia) according to the manufactur-
er’s protocol. The resulting cDNA was then diluted in RNase-free water and pre-amplified
using a miScript PreAMP PCR Kit (Cat No. 331452; Qiagen, Australia) according to the manu-
facturer’s specifications. Pre-amplified cDNA was then diluted in RNase-free water and stored
at -20°C.
Real-Time PCR
Quantification of miRNAs was performed on a Qiagen customized 96-well miScript miRNA
PCR Array (Custom Catalogue Number: CMIHS02269). The array contained positive and
reverse transcription controls, and 13 miRNAs selected a priori from previous studies showing
changes following exercise, dietary intervention and/ or weight loss including: hsa-miR-21-5p,
hsa-miR-126-3p, hsa-miR-140-5p, hsa-miR-142-3p, hsa-miR-148a-5p, hsa-miR-148b-5p, hsa-
miR-199a-3p, hsa-miR-221-3p, hsa-miR-223-3p, hsa-miR-423-5p, hsa-miR-589-3p, hsa-miR-
874-5p and hsa-miR-935. PCR arrays were run using a miScript SYBR Green PCR Kit (218073;
Qiagen, VIC Australia) with microRNA abundance normalized to cel-miR-39-3p abundance,
and expression was not different at either time point or between groups (P = 0.77). The 2ΔΔCT
method of relative quantification was used to calculate the relative abundance of miRNAs in
plasma [18]. Where the relative abundance of miRNAs in plasma were>3 SD from the mean,
measures were excluded from analysis at both time points (i.e. pre and post).
Selection of Predicted miRNA Targets
The Targetscan bioinformatics algorithm (Version 6.2, www.targetscan.org) was used for target
prediction of miRNAs altered between high and low responders or pre to post intervention for
those that were determined to be statistically significant (P<0.05).
Statistical analysis
To estimate whether differences between time points were statistically significant, a linear
mixed model with an AR1 covariance matrix was used for each outcome measure. The interac-
tion between time × group was included to allow the groups to change differently over time
and to obtain least significant difference (LSD) post hoc comparisons of group within time. As
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this was an exploratory study, no adjustments were made for multiple comparisons in order to
avoid type II errors [19]. Independent sample t-tests were used to assess baseline participant
characteristics pre intervention and baseline differences in c-miRNA expression where main
effects were observed. Linear regression analysis was performed to assess the relationship
between baseline participant characteristics and baseline c-miRNA abundance, and between
changes in participant characteristics and c-miRNA abundance pre- and post-intervention.
Data are mean ± standard deviation (SD) and were analysed using SPSS (Version 20.0) with
significance set at P<0.05.
Results
Participant characteristics
The mean age of participants was 47 ± 6 y. Forty-nine individuals lost5% or10% of their
initial body mass after the 16 wk intervention. Participant characteristics pre and post interven-
tion are listed in Table 1.
Nine participants were excluded from analysis: six (n = 4 HiRes/n = 2 LoRes) through blood
sample haemolysis and three with missing samples (n = 2 HiRes/n = 1 LoRes) (Fig 1). There-
fore, 18 LoRes and 22 HiRes participants were included in the final analysis and each diet inter-
vention was represented in both the HiRes (n = 8 HPMC, n = 5 HPHC, n = 9 CON) and LoRes
(n = 6 HPMC, n = 9 HPHC, n = 3 CON) groups.
Plasma c-miRNA
The c-miR-221-3p and -223-3p abundance increased across time from pre- to post-interven-
tion in both groups (57–69% and 25–90%, P = 0.04 and P = 0.05, respectively; Fig 2B and 2C).
There was a significant effect for time for c-miR-223 (P = 0.05) as a result of the increase in
expression above baseline in HiRes after the intervention (Fig 2C; P = 0.038). A group differ-
ence was observed for c-miR-935 (P = 0.001), where c-miR-935 was the only microRNA differ-
entially expressed at baseline being higher in LoRes than HiRes (47%; P = 0.046, Fig 2D,
Table 2). Such a difference in c-miR-935 was still evident at the conclusion of the 16 wk inter-
vention period (100%; P<0.001). A group difference for c-miR-140 was evident (P = 0.016)
and post hoc tests showed no difference between responders at baseline for c-miR-140 but an
increase in expression in LoRes (23%) compared to HiRes post-intervention (8%, P = 0.014).
There were modest effects of the 16 wk weight loss intervention on the abundance of other c-
miRNA targets (Table 2). Raw plasma c-miRNA Ct data can be found in the S2 Dataset.
Target prediction of altered c-miRNAs
TargetScan identified 345 predicted targets for c-miR-140, 448 for c-miR-221, 310 for c-miR-
223 and 263 for c-miR-935. Of these, predicted targets related to obesity, diabetes, substrate
metabolism and physiological adaptation responses to exercise (e.g. mitochondrial biogenesis,
muscle hypertrophy) were further classified (Table 3).
Anthropometric, diet and changes in aerobic fitness
There were no differences in body mass, BMI and fat mass between groups at baseline
(Table 1). The HiRes participants lost 8 kg more body mass (P<0.01) and 7.2 kg more fat mass
(P = 0.03), than LoRes respectively, with significant group × time interactions (both P<0.01).
A corresponding decrease in BMI was also evident for HiRes compared to LoRes following the
16 wk intervention period (P = 0.02) where an interaction effect was also observed (P<0.001).
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Using the Mifflin St Jeor equation [15] for sedentary individuals, the energy requirements of
HiRes and LoRes were 2081 ± 352 kcal/d and 2174 ± 202 kcal/d, respectively. Dietary analysis
of individual food diaries obtained during the diet intervention showed the reported energy
intake was not different between groups (HiRes: 1622 ± 262 kcal/d (n = 18) vs. LoRes:
1606 ± 136 kcal/d (n = 15), P = 0.84). Pre-intervention peak aerobic power (VO2peak) did not
differ between groups (HiRes: 2.21 ± 0.68 L/min; LoRes: 2.20 ± 0.56 L/min, P = 0.97), and was
significantly increased (P<0.001) by the same magnitude in response to exercise training
(HiRes: 0.27 ± 0.19 L/min, LoRes: 0.25 ± 0.18 L/min, P = 0.70).
Blood parameters
At baseline, fasting blood glucose was higher in HiRes than LoRes (Table 1, P = 0.008), with a
significantly greater decrease in blood glucose in HiRes over the 16 wk intervention than LoRes
(P<0.001). The area under the curve (AUC) from the OGTT was also greater in HiRes com-
pared with LoRes pre-intervention (Table 1, P = 0.006). The 16 wk intervention resulted in a
reduction in glucose AUC (-91 ± 117; P<0.01) across both groups that was significant for
HiRes (P<0.001), but not the LoRes group (P = 0.07). A group × time interaction effect was
observed for insulin concentration (P = 0.05). Insulin concentrations were not different
between groups at baseline (HiRes: 8.1 ± 5.4 mIU/mL vs. LoRes: 7.3 ± 6.0 mIU/mL, P = 0.60)
but decreased significantly over the 16 wk intervention in the HiRes group only (HiRes:
-2.9 ± 4.1 mIU/mL, P<0.001; LoRes: -1.2 ± 3.9 mIU/mL; P = 0.51). No differences in HOMA
index were observed between groups despite a decrease across time (HiRes, Pre: 2.15 ± 1.69,
Post: 1.21 ± 0.75; LoRes, Pre: 1.80 ± 1.63, Post: 1.61 ± 1.27 P = 0.003) with a significant
group × time interaction (P = 0.045).
Relationships between c-miRNAs and anthropometric measures
Regression equations were used to show the abundance of several baseline c-miRNA’s were
weakly associated with pre-intervention body mass including c-miR-221 (P = 0.02, R2 = 0.15),
c-miR-21 (P = 0.01, R2 = 0.16) and c-miR-126 (P = 0.05, R2 = 0.10). These weak associations
explained less than 20% of the variance between baseline c-miRNA abundance and pre-inter-
vention body mass. There were no relationships between baseline c-miRNA abundance and
pre-intervention fat mass, lean mass or BMI, while a weak relationship was found between
Table 1. Participant characteristics measured pre and post intervention of High (HiRes) and low (LoRes) responders to the 16 week diet and exer-
cise intervention.
Low responders (n = 18) High responders (n = 22) P values
Pre Post Pre Post Group Time Interaction
Age (years) 46.3 ± 5.7 - 48.2 ± 6.2 - - - -
Body mass (kg) 94.4 ± 11.7 92.3 ± 12.0# 89.9 ± 14.2 82.8 ± 12.1#* P = 0.04 P<0.01 P<0. 01
Body Mass Index (kg/m2) 33.6 ± 4.7 32.5 ± 4.5# 31.9 ± 3.7 27.9 ± 3.3#* P = 0.02 P<0.001 P<0.001
Fat mass (kg) 41.2 ± 11.2 37.4 ± 12.0# 37.5 ± 8.7 26.4 ± 8.3#* P = 0.03 P<0.01 P<0.001
Lean mass (kg) 50.2 ± 8.2 51.1 ± 8.1# 49.3 ± 9.5 49.5 ± 9.7 NS P = 0.05 NS
Fasting blood glucose concentration (mmol/L) 5.3 ± 0.5 5.3 ± 0.5 5.8 ± 0.7* 5.4 ± 0.6# NS P = 0.02 P<0.01
Oral glucose tolerance test AUC (AU) 210 ± 104 159 ± 78 316 ± 153* 186 ± 88# P = 0.04 P<0.001 P = 0.05
Data are mean ± SD; P<0.05:
# difference between time points within condition
* difference between groups within time points
doi:10.1371/journal.pone.0152545.t001
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baseline c-miR-140 and age (P = 0.04, R2 = 0.11). There were no significant relationships
between the change in c-miRNA abundance and the changes in total, fat or lean masses as a
result of the 16 wk diet and exercise intervention.
Discussion
This is the first study to characterise changes in targeted c-miRNAs in a cohort of high and low
responders to a chronic diet- and exercise intervention in overweight/obese individuals. We
report altered expression of c-miRNA-140 and -935 in human plasma that were associated
with differences in the magnitude of change in body mass, along with differential changes in
the expression of c-miRNA-221 and -223 pre- to post-intervention. These findings provide
novel information that may link these c-miRNA to the beneficial effects of exercise- and diet-
induced energy restriction for weight loss.
Fig 2. Plasma c-miR abundance prior to and after a 16 week diet and exercise weight loss intervention for high responders (HiRes, n = 22) and low
responders (LoRes, n = 18) A: c-miR-140, B: c-miR-221; C: c-miR-223, and D: c-miR-935; data are mean ± SD; P<0.05: ‡ difference pre vs post,
* difference HiRes vs LoRes.
doi:10.1371/journal.pone.0152545.g002
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Diet- and exercise-based weight loss interventions result in large variability in responses
between individuals that is often under-reported [24]. The expression profile of particular c-
miRNAs have emerged as promising ‘biomarkers’ for certain disease states, raising the possibil-
ity that the regulation of c-miRNA may be involved in the heterogeneity in body composition
changes between individuals during interventions aimed at losing body mass. By utilising pre-
vious studies that had demonstrated robust changes in c-miRNA following exercise, energy
restriction or surgical interventions with putative roles in weight loss, we identified 13 c-
miRNA for analysis [4,11,25,26]. Results from the current study show increased levels of c-
miR-935 in the LoRes compared to HiRes at baseline and increases in c-miR-140, -221 and
-223 abundance following a 16 wk weight-loss intervention. We are the first to report a selec-
tive increase in c-miR-140 abundance in participants with small (LoRes) compared to those
with a larger change in body mass (HiRes) in response to an energy restricted diet and exercise
weight-loss intervention. Increased basal c-miR-140 abundance has been reported in obese/
morbidly obese groups and was markedly reduced after bariatric surgery [11], although its
expression was unchanged following a diet-only weight loss intervention [11]. Furthermore,
higher c-miR-140 abundance has been reported in individuals with a high (BMI 40 kg/m2)
compared to normal (BMI 30 kg/m2) body mass [11].
A putative target of c-miR-140 is the muscle integral membrane protein FNDC5. The hor-
mone irisin, the proteolytically processed product of the FNDC5 gene, is secreted by skeletal
muscle cells in response to exercise where it has been shown to circulate to white adipose tissue
and stimulate ‘beige’ fat development [27]. It is possible the higher c-miR-140 expression post-
intervention only in LoRes downregulates FNDC5 activity and subsequently reduces its ability
to promote weight loss through reduced energy expenditure.
The increased expression of c-miR-935 in LoRes compared to the HiRes group (Fig 2D) is
in agreement with previous findings of higher c-miR-935 abundance at baseline in a group of
non-responders (<5% body weight) to a low energy (~850 kcal/d) diet-only weight-loss inter-
vention [4]. Using the TargetScan algorithm, several predicted targets of c-miR-935 were iden-
tified with purported roles in various exercise-mediated adaptations and energy metabolism
(Table 3). It is currently unknown if this disparity in baseline c-miR-935 abundance between
the HiRes and LoRes groups up- or down-regulates the expression of these targets in a tissue-
Table 2. Plasma c-miRNA abundance at baseline (pre-intervention) and the relative fold change in abundance after a 16 wk diet and exercise inter-
vention in low and high responders for weight loss.
c-miRNA Pre-intervention Relative fold change
Low responders (n = 18) High responders (n = 22) P-value Low responders (n = 18) High responders (n = 22) P value
miR-21-5p 2.47 ± 2.44 1.94 ± 2.30 0.96 0.28 ± 0.88 -0.05 ± 1.11 0.30
miR-126-3p 1.41 ± 1.10 1.16 ± 0.85 0.41 0.27 ± 1.16 0.25 ± 1.24 0.84
miR-140-5p 1.34 ± 0.91 0.92 ± 0.72 0.12 0.23 ± 0.66 0.07 ± 1.04 0.44
miR-142-3p 1.42 ± 1.03 0.98 ± 0.75 0.12 -0.02 ± 0.95 0.22 ± 1.08 0.54
miR-148a-5p 1.15 ± 0.76 0.92 ± 0.67 0.35 -0.10 ± 1.11 -0.02 ± 0.67 0.75
miR-148b-5p 1.39 ± 1.26 0.82 ± 0.63 0.08 -0.03 ± 1.08 0.97 ± 2.76 0.34
miR-199a-3p 2.50 ± 2.45 1.39 ± 1.42 0.08 0.19 ± 1.41 0.72 ± 1.87 0.60
miR-221-3p 1.28 ± 1.22 1.09 ± 1.06 0.62 0.51 ± 1.43 0.63 ± 1.97 0.97
miR-223-3p 1.75 ± 1.50 1.36 ± 1.38 0.42 0.25 ± 1.48 0.82 ± 1.77 0.34
miR-423-5p 1.11 ± 0.58 1.18 ± 0.94 0.80 0.14 ± 0.76 0.65 ± 1.40 0.68
miR-589-3p 1.37 ± 1.03 0.88 ± 1.22 0.20 0.04 ± 1.42 0.22 ± 1.22 0.78
miR-874-5p 1.12 ± 0.79 0.81 ± 0.54 0.17 0.21 ± 1.10 0.18 ± 1.33 0.84
miR-935 1.06 ± 0.52 0.72 ± 0.35 0.03 0.17 ± 0.74 -0.12 ± 0.59 0.18
doi:10.1371/journal.pone.0152545.t002
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specific manner (i.e. adipose tissue, skeletal muscle, etc.). However, of note was that the differ-
ential expression persisted after the intervention. Regardless, our findings support those of
Milagro and colleagues [4] and provide further evidence that c-miR-935 may act as a ‘bio-
marker’ to differentiate between individuals with high and low responses in weight loss.
Recent evidence from overweight and obese humans suggests c-miR-223 as a potential bio-
marker for obesity [28,29]. Indeed, reduced c-miR-223 levels have been observed in morbidly
obese (BMI>40 kg/m2) and obese (BMI 30–39.9 kg/m2) compared to normal-overweight
individuals (BMI 20–29.9 kg/m2) [28]. Moreover, c-miR-223 abundance has been shown to
increase after a 12 wk unstructured dietary and exercise intervention in obese and overweight
participants [29]. These results indicate that increases in c-miR-223 are associated with diet
and exercise interventions that result in loss of body mass. The increases in c-miR-223 with
weight loss is in agreement with our findings as we report increased c-miR-223 and -221 abun-
dance post-intervention in both HiRes and LoRes groups. Previous reports of c-miR-221
responses to dietary or exercise interventions are equivocal, with a single study showing a
decrease in c-miR-221 three days after a bout of resistance exercise [26] while another reported
increased c-miR-221 abundance after bariatric surgery and subsequent weight loss but not die-
tary-induced weight loss [11]. Thus, the increase in c-miR-221 abundance across the 16 wk
intervention in both LoRes and HiRes (Fig 2B) indicates these changes are most likely related
to the exercise stimulus rather than being diet-induced.
Although participants were grouped according to a loss of body mass, glucose tolerance was
also different between groups at baseline, with higher fasting glucose concentration and a
greater area under the curve for OGTT in HiRes. Therefore, it is plausible the reduced glucose
sensitivity at baseline conferred greater likelihood of observing a change in sensitivity and sub-
sequent weight loss, and that enhanced glucose disposal/glycaemic stability in response to the
exercise and diet intervention may be a hallmark of HiRes. While the c-miR-126 has been
implicated as a biomarker for impaired fasting glucose and glucose tolerance [30], we found no
difference in c-miR-126 abundance between HiRes and LoRes groups, suggesting any potential
for c-miR-126 modulation with impaired glucose metabolism may be limited to a pre-diabetic
population [30]. Nonetheless, glucose tolerance may still be an underlying determinant for pre-
dicting a weight loss responder to an exercise and diet intervention.
The divergent loss of body mass between HiRes and LoRes does not appear to be related to
the adaptive responses to endurance exercise as no differences were observed post-intervention
in aerobic fitness (VO2peak) between the two groups. Further, only weak correlations were
found between baseline body mass, BMI, or fat mass measures and selected c-miRNA abun-
dance in the current study and no significant correlations between changes in anthropometric
measures and changes in c-miRNA abundance were observed. These results contrast those of
Milagro and colleagues [4] who reported strong correlations between several miRNA’s mea-
sured in peripheral blood mononuclear cells and the magnitude of weight loss (n = 10). How-
ever, a strength of the current study was the larger participant cohort (n = 40) to provide a
greater representation of the overweight/obese population. The inclusion of exercise in addi-
tion to dietary energy restriction to generate the overall energy deficit may also have contrib-
uted to disparity in results between studies.
A limitation of the present work, and other studies that have investigated c-miRNA
responses in humans to exercise and diet interventions, is the lack of concomitant sampling of
tissues (i.e. skeletal muscle and adipose tissue) in which c-miRNAs may originate or target in
order to mediate specific cellular processes regulating weight loss. Simultaneous measurements
of muscle and adipose tissues would provide an integrated approach to better understand the
interplay and ‘cross talk’ between different tissues to a given stimulus, such as a weight loss
intervention. The time-course of appearance and disappearance of individual c-miRNAs
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following an exercise and diet intervention also remains to be established and may vary accord-
ing to the length of intervention and the time in which samples were obtained.
In conclusion, this is the first study to report the expression profile of selected c-miRNAs
following a structured exercise and diet weight loss intervention. This study provides new
information demonstrating that the abundance of c-miRNA -221 and -223 are modulated with
exercise and diet, and that c-miRNA -935 and 140 are differentially expressed between high
and low responders before and after a chronic weight loss intervention. Our findings reveal the
potential for c-miRNAs to act as ‘biomarkers’ regulating the magnitude of weight loss to an
exercise and diet intervention between different individuals. In vitromechanistic studies in
cell culture and animal knockout models are required to validate the regulation of target pro-
teins by their specific c-miRNAs. Further research using larger participant cohorts over longer
interventions will be important for determining whether c-miRNAs regulate cellular mecha-
nisms controlling weight loss and therefore become accurate biomarkers for obesity risk and
development.
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